SMARCB1 and chordoma: SMARCB1 mutations have been detected in rhabdomyoma, familial schwannomatosis, small cell hepatic fibroblastoma, skeletal extracellular myxoid chondrosarcoma, undifferentiated sarcoma, epithelial sarcoma, meningiomas and poorly differentiated chordomas.